1. Phase II clinical trial testing the safety of a humanised monoclonal antibody anti-CD20 in patients with heart failure with reduced ejection fraction, ICFEr-RITU2: study protocol. Issue 3 (27th March 2019) Authors: Sánchez-Trujillo, Luis; Jerjes-Sanchez, Carlos; Rodriguez, David; Panneflek, Jathniel; Ortiz-Ledesma, Claudia; Garcia-Rivas, Gerardo; Torre-Amione, Guillermo Journal: BMJ open Issue: Volume 9:Issue 3(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗